Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase NA 30Phase 1/2 30Phase 1 30Phase EARLY_PHASE1 7Phase 3 5Phase 4 3Phase 2/3 3

Status

Completed 57Unknown 18Terminated 10Recruiting 7Not yet recruiting 5Withdrawn 3Active not recruiting 3Enrolling by invitation 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 16Breast 12Tumor-Agnostic 5Thoracic 5Lymphoid 5Genitourinary 4CNS 4Plasma cell 3Other hematologic neoplasm 3Head & Neck 3Dermatologic 3Classical hematology 3Gynecologic 2Other 1NET 1Myeloid 1Endocrine 1

Conditions

Melanoma 2Ovarian Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Keratosis, Actinic 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

tirbanibulin 1encorafenib 1binimetinib 1Patient-Specific Modeling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Dermatologic × Clear all
NCT07092410 2026-04-21

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Withdrawn
Dermatologic

Melanoma

NCT06026358 2024-05-30

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

Medical University of Graz

Phase 4 Withdrawn
Dermatologic

Keratosis, Actinic

NCT02000739 2014-07-14

GENIUS

Dartmouth-Hitchcock Medical Center

Phase 4 Withdrawn
BreastCNSDermatologicGastrointestinalGynecologicHead & NeckThoracic

Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡